0.2 |
0.6 |
GO:0001907 |
cytolysis by symbiont of host cells(GO:0001897) killing by symbiont of host cells(GO:0001907) hemolysis by symbiont of host erythrocytes(GO:0019836) disruption by symbiont of host cell(GO:0044004) hemolysis in other organism(GO:0044179) positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) cytolysis in other organism(GO:0051715) cytolysis in other organism involved in symbiotic interaction(GO:0051801) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 |
0.1 |
GO:0045938 |
positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
0.1 |
1.0 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) |
0.1 |
0.3 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
0.1 |
0.4 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 |
0.3 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) actin filament reorganization(GO:0090527) |
0.1 |
0.8 |
GO:0031498 |
nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 |
0.2 |
GO:0060649 |
nipple development(GO:0060618) mammary gland bud elongation(GO:0060649) nipple morphogenesis(GO:0060658) nipple sheath formation(GO:0060659) |
0.1 |
0.3 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) |
0.1 |
0.5 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
0.0 |
0.9 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) |
0.0 |
0.5 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
0.0 |
0.1 |
GO:0003011 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 |
0.1 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
0.0 |
0.3 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
0.0 |
0.1 |
GO:0046671 |
regulation of nitrogen utilization(GO:0006808) positive regulation of neuron maturation(GO:0014042) nitrogen utilization(GO:0019740) cochlear nucleus development(GO:0021747) negative regulation of cellular pH reduction(GO:0032848) glial cell apoptotic process(GO:0034349) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) positive regulation of cell maturation(GO:1903431) |
0.0 |
0.1 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
0.0 |
0.2 |
GO:0060414 |
aorta development(GO:0035904) aorta morphogenesis(GO:0035909) aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 |
0.1 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
0.0 |
0.2 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 |
0.2 |
GO:1902622 |
regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.0 |
0.1 |
GO:0000917 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) mitotic cytokinetic process(GO:1902410) |
0.0 |
0.3 |
GO:0006400 |
tRNA modification(GO:0006400) |
0.0 |
0.3 |
GO:0031000 |
response to caffeine(GO:0031000) |
0.0 |
0.1 |
GO:0050957 |
equilibrioception(GO:0050957) |
0.0 |
0.1 |
GO:0097061 |
dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 |
0.4 |
GO:0008347 |
glial cell migration(GO:0008347) |
0.0 |
0.1 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
0.0 |
0.1 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
0.0 |
0.5 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
0.0 |
0.1 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
0.0 |
0.4 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
0.0 |
0.3 |
GO:0007172 |
signal complex assembly(GO:0007172) |
0.0 |
0.1 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 |
0.3 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
0.0 |
0.0 |
GO:0072369 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.0 |
0.1 |
GO:0051597 |
response to methylmercury(GO:0051597) |